Information
FRAXA Research Foundation Features GEXVal's Development Program

GEXVal Inc.January 6, 2025 We are delighted to announce that FRAXA Research Foundation1) has featured GEXVal I […]

Read more
R&D
GEXVal Selected for AMED’s ‘Strengthening Program for Pharmaceutical Startup Ecosystem’

GEXVal Inc.16 December, 2024 We are delighted to announce that GEXVal Inc.'s planned global Phase 2a Proof of […]

Read more
Information
GEXVal Participates in BIO-EUROPE® 2024

Read more
Information
GEXVal Selected as Finalist for CITELINE JAPAN AWARDS 2024 in Categories: EXECUTIVE OF THE YEAR & FINANCING DEAL OF THE YEAR

GEXVal Inc.October 8, 2024   We are honored to announce that GEXVal Inc. (President and CEO: Juran Kato, PhD; […]

Read more
Information
GEXVal Showcases Innovation: Speaking and Exhibiting at Three Premier Japanese Biotech Events at BioJapan 2024 

GEXVal Inc. October 3, 2024    GEXVal Inc. (President and CEO: Juran Kato, PhD; Location: Fujisawa, Kanagawa, […]

Read more